Samuraciclib (hydrochloride), CAS [[1805789-54-1]]

Produktübersicht

• Artikelname: Samuraciclib (hydrochloride), CAS [[1805789-54-1]]
• Artikelnummer: MCE-HY-103712A
• Hersteller Artikelnummer: HY-103712A
• Alternativnummer: MCE-HY-103712A-1MG,MCE-HY-103712A-10MMX1ML,MCE-HY-103712A-25MG,MCE-HY-103712A-100MG,MCE-HY-103712A-5MG,MCE-HY-103712A-50MG,MCE-HY-103712A-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: CT7001 (hydrochloride), ICEC0942 (hydrochloride)

Produktbeschreibung

Samuraciclib hydrochloride (CT7001 hydrochloride) is a potent, selective, ATP-competitive and orally active CDK7 inhibitor, with an IC50 of 41 nM. Samuraciclib hydrochloride displays 45-, 15-, 230- and 30-fold selectivity over CDK1, CDK2 (IC50 of 578 nM), CDK5 and CDK9, respectively. Samuraciclib hydrochloride inhibits the growth of breast cancer cell lines with GI50 values between 0.2-0.3 µM. Samuraciclib hydrochloride has anti-tumor effects[1][2].

Produkteigenschaften

• Molekulargewicht: 430.97
• Reinheit: 99.98
• CAS Nummer: [1805789-54-1]
• Formel: C22H31ClN6O
• Target-Kategorie: Apoptosis,CDK

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound